Type 2 diabetes mellitus and atherogenic dyslipidemia: Which statin is most effective in the primary prevention of cardiovascular events?

QR Code

Type 2 diabetes mellitus and atherogenic dyslipidemia: Which statin is most effective in the primary prevention of cardiovascular events?

Background: Type 2 diabetics are at high risk of atherosclerosis and cardiovascular (CV) events due to their associated dyslipidemic profile. Adverse levels of the lipid triad: low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TGs), have bee...

Full description

Bibliographic Details
Main Author:	Figg, Gemma
Format:	Dissertation (University of Nottingham only)
Language:	English
Published:	2012
Online Access:	https://eprints.nottingham.ac.uk/26938/

Similar Items

Vascular complications in type 2 diabetes mellitus patients and their association with hypertension and dyslipidemia
by: Khalid, Mohd Khairul Ashraf
Published: (2018)

Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus
by: Hammad, Mohamed Anwar, et al.
Published: (2017)

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: Protocol for a randomised controlled trial in primary care (STAREE trial)
by: Zoungas, S., et al.
Published: (2023)

Arterial Stiffness, Inflammatory And Atherogenic Markers In Gestational Diabetes
by: Aziz, Salmi Ab
Published: (2011)

Cryptotanshinone inhibits TNF-α-induced early atherogenic events in vitro
by: Ahmad, Zuraini, et al.
Published: (2016)

Predictors of cardiovascular disease in patients with type 2 diabetes mellitus
by: Tan, Mun Ching, et al.
Published: (2013)

Statin therapy prescribing for patients with type 2 diabetes mellitus: a review of current evidence and challenges
by: Elnaem, Mohamed Hassan Abdelaziz, et al.
Published: (2017)

Dyslipidemia control and adverse drug reactions of statins among patients at cardiac clinic of Penang Hospital, Malaysia[RS1-441].
by: Alrazzaq, Hadeer Akram Abdul
Published: (2009)

Prevalence and risk factors for dyslipidemia and hypertension in diabetes mellitus among the paediatric population in Hospital Universiti Sains Malaysia (USM), Kelantan, Malaysia
by: Shawaludin, Mohamad Qazreen Ahmad
Published: (2023)

Factors associated with cardiovascular disease in patients with type 2 diabetes mellitus
by: Tan, Mun Chieng
Published: (2013)

Telmisartan to prevent recurrent stroke and cardiovascular events
by: Yusuf, Salim, et al.
Published: (2008)

Prevalence of arterial stiffness and dyslipidemia
by: Abdul Kareem, Azmad, et al.
Published: (2012)

Patterns of statin therapy prescribing among hospitalized patients with type 2 diabetes mellitus in two Malaysian tertiary hospitals
by: Elnaem, Mohamed Hassan Abdelaziz, et al.
Published: (2017)

Arterial stiffness and its association with dyslipidemia
by: Mohd Rus, Razman, et al.
Published: (2013)

Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012)

Application of Mediterranean diet in cardiovascular diseases and Type 2 diabetes mellitus: motivations and challenges
by: Salim AlAufi, Najwa, et al.
Published: (2022)

Evaluation of statin therapy prescribing among hospitalized patients with type 2 diabetes mellitus: findings from two Malaysian tertiary hospitals
by: Elnaem, Mohamed Hassan Abdelaziz, et al.
Published: (2017)

Evaluation Of Combined Metformin-Lovastatin Therapy In The Treatment Of Diabetic Type 2 Patients With Dyslipidemia In Hospital Pulau Pinang
by: Ghaith, Nada Faisal Zaki
Published: (2010)

PCSK9 inhibitors and dyslipidemia: The clinical evidence
by: Norata, Giuseppe
Published: (2014)

Re: Managing dyslipidaemia for the primary prevention of cardiovascular disease
by: Hippisley-Cox, Julia
Published: (2018)

Pharmacometrics Time-To-Event And Disease Progression Modelling Of Diabetic Nephropathy In Patients With Type ii Diabetes Mellitus In Malaysia
by: Aziz, Sohail
Published: (2024)

In Vitro Effects of Cryptotanshinone on Early Atherogenic Events Induced by Oxidized Low Density Lipoprotein and Tumour Necrosis Factor-α
by: Ang, Kok Pian
Published: (2010)

Impact of educational outreach intervention on enhancing health care providers' knowledge about statin therapy prescribing in Malaysian patients with type 2 diabetes mellitus
by: Elnaem, Mohamed Hassan Abdelaziz, et al.
Published: (2018)

Metformin Use beyond Diabetes: Reducing Cardiovascular Events in the Healthy Elderly
by: Xu, Daniel, et al.
Published: (2020)

Physical activity, nutrition, and dyslipidemia in middle-aged women
by: Delavar, Mouloud Agajani, et al.
Published: (2011)

Cardiovascular disease risk factors assessment and glycemic control among type-2 diabetes mellitus patients : a comparative study between primary care and diabetic specialist clinic in Kuantan, Pahang
by: Abdullah, Fa’iza, et al.
Published: (2015)

The effects of methanolic extract of clinacanthus nutans L. (belalai gajah) on atherogenic risk markers in a type 2 diabetic rat model
by: Azemi, Ahmad Khusairi
Published: (2021)

The association of cardiovascular disease with impaired health-related quality of life among patients with type 2 diabetes mellitus
by: Tan, Mun Chieng, et al.
Published: (2014)

Licensed medicines, off-label use or evidence based: which is most important?
by: Bonati, Maurizio, et al.
Published: (2016)

Co-morbidity and cardiovascular risk assessment among Type-2 diabetes mellitus patients: A preliminary study at a public primary care clinic in Kuantan, Malaysia
by: Tin, Myo Han, et al.
Published: (2015)

The changes in glycemic control and cardiovascular risks among type 2 diabetes mellitus patients in Kelantan enhanced primary healthcare clinics pre and post-covid-19 pandemic
by: Sukeri, Nur Hafizah
Published: (2023)

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study
by: Morling, Joanne R., et al.
Published: (2015)

Analysis of primary prevention services for cardiovascular disease in Australia's community pharmacies
by: Joyce, Andrew, et al.
Published: (2007)

A systematic review of the evidence for pharmacist care of patients with dyslipidemia
by: Charrois, Theresa, et al.
Published: (2012)

Gestational Diabetes Mellitus in Far North Queensland, Australia, 2004 to 2010: Midwives' perinatal data most accurate source
by: Chamberlain, C., et al.
Published: (2013)

Effectiveness of Mediterranean diet on diabetic control and cardiovascular risk modification among patients with type 2 diabetes mellitus in Oman: a study protocol
by: Salim, AlAufi Najwa, et al.
Published: (2022)

The Patterns Of Prescribing, Health Beliefs And Adherence To Statin Therapy Among Patients With High Cardiovascular Disease Risk And Health Care Providers’ Knowledge, Attitude, Barriers And Practice Regarding Cardiovascular Risk Assessment And Statin Therapy In Yemen
by: Al-Ashwal, Fahmi Yahya Ahmed
Published: (2022)

Analysis of selected glutathione S-transferase gene polymorphisms in Malaysian type 2 diabetes mellitus patients with and without cardiovascular disease
by: Etemad, Ali, et al.
Published: (2016)

Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults
by: Zhou, Z., et al.
Published: (2020)

Bromocriptine for type 2 diabetes mellitus
by: Ooi, Cheow Peng, et al.
Published: (2013)